Hap Trading, LLC Geron Corp Call Options Transaction History

Hap Trading, LLC

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$2.03 - $2.42 $63,944 - $76,230	-31,500 Reduced 46.67%	36,000 $20,000
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $16,199 - $28,518	9,700 Added 16.78%	67,500 $36,000
Q2 2022 Aug 12, 2022	BUY	$1.19 - $1.65 $5,712 - $7,920	4,800 Added 9.06%	57,800 $10,000
Q1 2022 May 12, 2022	SELL	$0.99 - $1.6 $3,960 - $6,400	-4,000 Reduced 7.02%	53,000 $11,000
Q4 2021 Feb 14, 2022	SELL	$1.22 - $1.72 $244 - $344	-200 Reduced 0.35%	57,000 $9,000
Q3 2021 Nov 10, 2021	SELL	$1.2 - $1.5 $1,080 - $1,350	-900 Reduced 1.55%	57,200 $11,000
Q2 2021 Aug 11, 2021	SELL	$1.25 - $1.83 $8,125 - $11,895	-6,500 Reduced 10.06%	58,100 $17,000
Q1 2021 May 14, 2021	BUY	$1.52 - $2.1 $1,672 - $2,310	1,100 Added 1.73%	64,600 $11,000
Q4 2020 Feb 16, 2021	BUY	$1.55 - $2.05 $50,685 - $67,035	32,700 Added 106.17%	63,500 $9,000
Q3 2020 Nov 13, 2020	BUY	$1.59 - $2.19 $8,904 - $12,264	5,600 Added 22.22%	30,800 $5,000
Q2 2020 Aug 10, 2020	BUY	$1.05 - $2.18 $15,645 - $32,482	14,900 Added 144.66%	25,200 $11,000
Q1 2020 May 08, 2020	BUY	$0.89 - $1.49 $9,167 - $15,347	10,300 New	10,300 $2,000
Q1 2019 May 10, 2019	SELL	$1.01 - $1.83 $19,392 - $35,136	-19,200 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$0.98 - $1.85 $89,376 - $168,720	-91,200 Reduced 82.61%	19,200 $1,000
Q3 2018 Nov 09, 2018	SELL	$1.76 - $6.38 $118,800 - $430,650	-67,500 Reduced 37.94%	110,400 $2,000
Q2 2018 Aug 13, 2018	BUY	$3.29 - $4.82 $585,291 - $857,478	177,900 New	177,900 $44,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.53B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.